Positioning of Tofacitinib in India is not clear but it is being prescribed in biologic naive groups because of low cost. Though cheap, it is not risk free. Here is a report of Tubercular Pleural effusion related to Tofacitinib use in ulcerative colitis doi.org/10.1093/ibd/iz…

Anuraag Jena Taylor & Francis Research Insights Shubhra Mishra Anupam Kumar Vishal Sharma Aravindsekar Nice. Congrats

Aline Charabaty, MD, FACG, AGAF #MondayNightIBD @southasianIBD Parakkal Deepak MD, MS, FACG Shrinivas Bishu Neha D. Shah MPH, RD, CNSC, CHES IBDesis Tina Aswani-Omprakash, MPH Neilanjan Nandi, MD, FACG, AGAF, FCCF, FACP Sharan Madhura Balasubramaniam Seb Sumit Bhatia Anjali Pandit, PhD Deepak James Shivaram P Singh Roshan Agarwala Steven Bollipo Keith Siau Shamsher Chauhan Rajat Khandelwal Dr Kailash Kolhe Anuraag Jena A 2/n ITB versus CD Clinical clues may offer some clarity .....but never a certainty regarding the underlying cause of the symptoms TBpeople #Tuberculosis #IBD #MNIBD #GITwitter #Medtwitter

Here is a tweetorial on Antitubercular therapy (ATT)-related hepatitis. This is based mainly on a lecture I took for DNB residents Here we begin 1/n⤵️

CME on Advanced Therapeutic Endoscopy @ RR( Army Hospital) , Delhi A different experience to cherish

Read a comprehensive review on the modern management of liver abscess published in the Journal of Gastrointestinal Infections #infection #GItwitter thieme.in/thieme-e-Journ…

Our review on abdominal tuberculosis, where we summarise all the evidence on gastrointestinal tuberculosis and peritoneal tuberculosis, has been published in Indian Journal of Gastroenterology Great effort by daya krishna Jha and Mythili Menon Pathiyil(she/her) link.springer.com/article/10.100…

Do you use antibiotics for IBD flares? If so, which antibiotics? Do read our review penned by daya krishna Jha and Shubhra Mishra in Indian Journal of Gastroenterology here link.springer.com/article/10.100…

1/n Tweetorial on Checklist for advanced therapies for inflammatory bowel disease Here is what I summarized. Credits to Beatriz Gros and Amith as I used some of their tweets for this presentation. I am sure there are areas of uncertainty, please do share your thought

It's GOOD NEWS !! The CITE SCORE has increased from 3.4 (2022) ➡️3.9 this year Do submit your research at Indian Journal of Gastroenterology

Our latest review on Latent TB in advanced therapy among IMIDs and IBD patients. Assessment and management for latent tuberculosis before advanced ther... sciencedirect.com/science/articl… Vishal Sharma Rinkal Kakadiya Anuraag Jena Anurag Sachan Partha Pal

We recently summarized our experience in respect to the mistakes that could happen while treating abdominal tuberculosis tandfonline.com/doi/full/10.10… Here is a summary of what we wrote 1/n

Here is the link to free full text for a limited period through the T&F Medicine & Healthcare tandfonline.com/eprint/EWJIKBR…